Compile Data Set for Download or QSAR
maximum 50k data
Found 106 with Last Name = 'griffen' and Initial = 's'
TargetHexokinase-4(Homo sapiens (Human))
Bristol Myers Squibb

Curated by ChEMBL
LigandPNGBDBM50585812(CHEMBL5091943)
Affinity DataIC50:  122nMAssay Description:Displacement of fluorescent labeled derivative from recombinant human hepatic glucokinase incubated for 30 mins in presence of 12 mM glucose by fluor...More data for this Ligand-Target Pair
TargetHexokinase-4(Homo sapiens (Human))
Bristol Myers Squibb

Curated by ChEMBL
LigandPNGBDBM50585813(CHEMBL5072532)
Affinity DataIC50:  123nMAssay Description:Displacement of fluorescent labeled derivative from recombinant human hepatic glucokinase incubated for 30 mins in presence of 12 mM glucose by fluor...More data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Departments Of Discovery Chemistry, Metabolic Diseases, Lead Evaluation, Computer-Assisted Drug Design, Discovery Toxicology, Exploratory Clinical And Translational Research, And Pharmaceutical Candi

Curated by ChEMBL
LigandPNGBDBM50026240(CHEMBL3338194)
Affinity DataIC50:  1.40E+3nMAssay Description:Inhibition of human ERG by patch clamp assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCytochrome P450 2C8(Homo sapiens (Human))
Bristol Myers Squibb

Curated by ChEMBL
LigandPNGBDBM50585813(CHEMBL5072532)
Affinity DataIC50:  7.70E+3nMAssay Description:Inhibition of CYP2C8 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCytochrome P450 2D6(Homo sapiens (Human))
Bristol Myers Squibb

Curated by ChEMBL
LigandPNGBDBM50585813(CHEMBL5072532)
Affinity DataIC50:  3.00E+4nMAssay Description:Inhibition of CYP2D6 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCytochrome P450 1A2(Homo sapiens (Human))
Bristol Myers Squibb

Curated by ChEMBL
LigandPNGBDBM50585813(CHEMBL5072532)
Affinity DataIC50:  3.00E+4nMAssay Description:Inhibition of CYP1A2 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCytochrome P450 2C9(Homo sapiens (Human))
Bristol Myers Squibb

Curated by ChEMBL
LigandPNGBDBM50585813(CHEMBL5072532)
Affinity DataIC50:  3.00E+4nMAssay Description:Inhibition of CYP2C9 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Departments Of Discovery Chemistry, Metabolic Diseases, Lead Evaluation, Computer-Assisted Drug Design, Discovery Toxicology, Exploratory Clinical And Translational Research, And Pharmaceutical Candi

Curated by ChEMBL
LigandPNGBDBM50585829(CHEMBL5092846)
Affinity DataIC50:  3.00E+4nMAssay Description:Inhibition of hERG by patch clamp methodMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetCytochrome P450 2C19(Homo sapiens (Human))
Bristol Myers Squibb

Curated by ChEMBL
LigandPNGBDBM50585813(CHEMBL5072532)
Affinity DataIC50:  3.00E+4nMAssay Description:Inhibition of CYP2C19 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCytochrome P450 3A4(Homo sapiens (Human))
Bristol Myers Squibb

Curated by ChEMBL
LigandPNGBDBM50585813(CHEMBL5072532)
Affinity DataIC50:  3.00E+4nMAssay Description:Inhibition of CYP3A4 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCytochrome P450 2B6(Homo sapiens (Human))
Bristol Myers Squibb

Curated by ChEMBL
LigandPNGBDBM50585813(CHEMBL5072532)
Affinity DataIC50:  3.00E+4nMAssay Description:Inhibition of CYP2B6 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Departments Of Discovery Chemistry, Metabolic Diseases, Lead Evaluation, Computer-Assisted Drug Design, Discovery Toxicology, Exploratory Clinical And Translational Research, And Pharmaceutical Candi

Curated by ChEMBL
LigandPNGBDBM50585830(CHEMBL5072442)
Affinity DataIC50:  3.30E+4nMAssay Description:Inhibition of hERG by patch clamp methodMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Departments Of Discovery Chemistry, Metabolic Diseases, Lead Evaluation, Computer-Assisted Drug Design, Discovery Toxicology, Exploratory Clinical And Translational Research, And Pharmaceutical Candi

Curated by ChEMBL
LigandPNGBDBM50585823(CHEMBL5081517)
Affinity DataIC50:  4.40E+4nMAssay Description:Inhibition of hERG by patch clamp methodMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Departments Of Discovery Chemistry, Metabolic Diseases, Lead Evaluation, Computer-Assisted Drug Design, Discovery Toxicology, Exploratory Clinical And Translational Research, And Pharmaceutical Candi

Curated by ChEMBL
LigandPNGBDBM50585812(CHEMBL5091943)
Affinity DataIC50:  5.00E+4nMAssay Description:Inhibition of hERG by patch clamp methodMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetATP-dependent translocase ABCB1(Homo sapiens (Human))
Bristol Myers Squibb

Curated by ChEMBL
LigandPNGBDBM50585813(CHEMBL5072532)
Affinity DataIC50:  5.50E+4nMAssay Description:Inhibition of P-gp transporter (unknown origin)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Departments Of Discovery Chemistry, Metabolic Diseases, Lead Evaluation, Computer-Assisted Drug Design, Discovery Toxicology, Exploratory Clinical And Translational Research, And Pharmaceutical Candi

Curated by ChEMBL
LigandPNGBDBM50585826(CHEMBL5085491)
Affinity DataIC50: >8.00E+4nMAssay Description:Inhibition of hERG by patch clamp methodMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Departments Of Discovery Chemistry, Metabolic Diseases, Lead Evaluation, Computer-Assisted Drug Design, Discovery Toxicology, Exploratory Clinical And Translational Research, And Pharmaceutical Candi

Curated by ChEMBL
LigandPNGBDBM50585824(CHEMBL5084870)
Affinity DataIC50: >8.00E+4nMAssay Description:Inhibition of hERG by patch clamp methodMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Departments Of Discovery Chemistry, Metabolic Diseases, Lead Evaluation, Computer-Assisted Drug Design, Discovery Toxicology, Exploratory Clinical And Translational Research, And Pharmaceutical Candi

Curated by ChEMBL
LigandPNGBDBM50585831(CHEMBL5076377)
Affinity DataIC50: >8.00E+4nMAssay Description:Inhibition of hERG by patch clamp methodMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Departments Of Discovery Chemistry, Metabolic Diseases, Lead Evaluation, Computer-Assisted Drug Design, Discovery Toxicology, Exploratory Clinical And Translational Research, And Pharmaceutical Candi

Curated by ChEMBL
LigandPNGBDBM50585832(CHEMBL5087489)
Affinity DataIC50: >8.00E+4nMAssay Description:Inhibition of hERG by patch clamp methodMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Departments Of Discovery Chemistry, Metabolic Diseases, Lead Evaluation, Computer-Assisted Drug Design, Discovery Toxicology, Exploratory Clinical And Translational Research, And Pharmaceutical Candi

Curated by ChEMBL
LigandPNGBDBM50585813(CHEMBL5072532)
Affinity DataIC50: >8.00E+4nMAssay Description:Inhibition of hERG by patch clamp methodMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Departments Of Discovery Chemistry, Metabolic Diseases, Lead Evaluation, Computer-Assisted Drug Design, Discovery Toxicology, Exploratory Clinical And Translational Research, And Pharmaceutical Candi

Curated by ChEMBL
LigandPNGBDBM50585833(CHEMBL5094606)
Affinity DataIC50: >8.00E+4nMAssay Description:Inhibition of hERG by patch clamp methodMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Departments Of Discovery Chemistry, Metabolic Diseases, Lead Evaluation, Computer-Assisted Drug Design, Discovery Toxicology, Exploratory Clinical And Translational Research, And Pharmaceutical Candi

Curated by ChEMBL
LigandPNGBDBM50585834(CHEMBL5077438)
Affinity DataIC50: >8.00E+4nMAssay Description:Inhibition of hERG by patch clamp methodMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Departments Of Discovery Chemistry, Metabolic Diseases, Lead Evaluation, Computer-Assisted Drug Design, Discovery Toxicology, Exploratory Clinical And Translational Research, And Pharmaceutical Candi

Curated by ChEMBL
LigandPNGBDBM50585835(CHEMBL5079866)
Affinity DataIC50: >8.00E+4nMAssay Description:Inhibition of hERG by patch clamp methodMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Departments Of Discovery Chemistry, Metabolic Diseases, Lead Evaluation, Computer-Assisted Drug Design, Discovery Toxicology, Exploratory Clinical And Translational Research, And Pharmaceutical Candi

Curated by ChEMBL
LigandPNGBDBM50585836(CHEMBL5082691)
Affinity DataIC50: >8.00E+4nMAssay Description:Inhibition of hERG by patch clamp methodMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Departments Of Discovery Chemistry, Metabolic Diseases, Lead Evaluation, Computer-Assisted Drug Design, Discovery Toxicology, Exploratory Clinical And Translational Research, And Pharmaceutical Candi

Curated by ChEMBL
LigandPNGBDBM50585837(CHEMBL5080166)
Affinity DataIC50: >8.00E+4nMAssay Description:Inhibition of hERG by patch clamp methodMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Departments Of Discovery Chemistry, Metabolic Diseases, Lead Evaluation, Computer-Assisted Drug Design, Discovery Toxicology, Exploratory Clinical And Translational Research, And Pharmaceutical Candi

Curated by ChEMBL
LigandPNGBDBM50585822(CHEMBL5083369)
Affinity DataIC50: >8.00E+4nMAssay Description:Inhibition of hERG by patch clamp methodMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Departments Of Discovery Chemistry, Metabolic Diseases, Lead Evaluation, Computer-Assisted Drug Design, Discovery Toxicology, Exploratory Clinical And Translational Research, And Pharmaceutical Candi

Curated by ChEMBL
LigandPNGBDBM50585821(CHEMBL5093978)
Affinity DataIC50: >8.00E+4nMAssay Description:Inhibition of hERG by patch clamp methodMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Departments Of Discovery Chemistry, Metabolic Diseases, Lead Evaluation, Computer-Assisted Drug Design, Discovery Toxicology, Exploratory Clinical And Translational Research, And Pharmaceutical Candi

Curated by ChEMBL
LigandPNGBDBM50585820(CHEMBL5093208)
Affinity DataIC50: >8.00E+4nMAssay Description:Inhibition of hERG by patch clamp methodMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Departments Of Discovery Chemistry, Metabolic Diseases, Lead Evaluation, Computer-Assisted Drug Design, Discovery Toxicology, Exploratory Clinical And Translational Research, And Pharmaceutical Candi

Curated by ChEMBL
LigandPNGBDBM50585819(CHEMBL5088988)
Affinity DataIC50: >8.00E+4nMAssay Description:Inhibition of hERG by patch clamp methodMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Departments Of Discovery Chemistry, Metabolic Diseases, Lead Evaluation, Computer-Assisted Drug Design, Discovery Toxicology, Exploratory Clinical And Translational Research, And Pharmaceutical Candi

Curated by ChEMBL
LigandPNGBDBM50585818(CHEMBL5080889)
Affinity DataIC50: >8.00E+4nMAssay Description:Inhibition of hERG by patch clamp methodMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Departments Of Discovery Chemistry, Metabolic Diseases, Lead Evaluation, Computer-Assisted Drug Design, Discovery Toxicology, Exploratory Clinical And Translational Research, And Pharmaceutical Candi

Curated by ChEMBL
LigandPNGBDBM50585817(CHEMBL5075882)
Affinity DataIC50: >8.00E+4nMAssay Description:Inhibition of hERG by patch clamp methodMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Departments Of Discovery Chemistry, Metabolic Diseases, Lead Evaluation, Computer-Assisted Drug Design, Discovery Toxicology, Exploratory Clinical And Translational Research, And Pharmaceutical Candi

Curated by ChEMBL
LigandPNGBDBM50585816(CHEMBL5086985)
Affinity DataIC50: >8.00E+4nMAssay Description:Inhibition of hERG by patch clamp methodMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Departments Of Discovery Chemistry, Metabolic Diseases, Lead Evaluation, Computer-Assisted Drug Design, Discovery Toxicology, Exploratory Clinical And Translational Research, And Pharmaceutical Candi

Curated by ChEMBL
LigandPNGBDBM50585814(CHEMBL5071861)
Affinity DataIC50: >8.00E+4nMAssay Description:Inhibition of hERG by patch clamp methodMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Departments Of Discovery Chemistry, Metabolic Diseases, Lead Evaluation, Computer-Assisted Drug Design, Discovery Toxicology, Exploratory Clinical And Translational Research, And Pharmaceutical Candi

Curated by ChEMBL
LigandPNGBDBM50585827(CHEMBL5088522)
Affinity DataIC50: >8.00E+4nMAssay Description:Inhibition of hERG by patch clamp methodMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Departments Of Discovery Chemistry, Metabolic Diseases, Lead Evaluation, Computer-Assisted Drug Design, Discovery Toxicology, Exploratory Clinical And Translational Research, And Pharmaceutical Candi

Curated by ChEMBL
LigandPNGBDBM50585825(CHEMBL5086686)
Affinity DataIC50: >8.00E+4nMAssay Description:Inhibition of hERG by patch clamp methodMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetGlucose-dependent insulinotropic receptor(Homo sapiens (Human))
Departments Of Discovery Chemistry, Metabolic Diseases, Lead Evaluation, Computer-Assisted Drug Design, Discovery Toxicology, Exploratory Clinical And Translational Research, And Pharmaceutical Candi

Curated by ChEMBL
LigandPNGBDBM50026067(CHEMBL3338186)
Affinity DataEC50: >1.00E+4nMAssay Description:Agonist activity at human GPR119More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlucose-dependent insulinotropic receptor(Homo sapiens (Human))
Departments Of Discovery Chemistry, Metabolic Diseases, Lead Evaluation, Computer-Assisted Drug Design, Discovery Toxicology, Exploratory Clinical And Translational Research, And Pharmaceutical Candi

Curated by ChEMBL
LigandPNGBDBM50026068(CHEMBL3338185)
Affinity DataEC50:  31nMAssay Description:Agonist activity at human GPR119More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlucose-dependent insulinotropic receptor(Homo sapiens (Human))
Departments Of Discovery Chemistry, Metabolic Diseases, Lead Evaluation, Computer-Assisted Drug Design, Discovery Toxicology, Exploratory Clinical And Translational Research, And Pharmaceutical Candi

Curated by ChEMBL
LigandPNGBDBM50026069(CHEMBL3338184)
Affinity DataEC50: >1.00E+4nMAssay Description:Agonist activity at human GPR119More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlucose-dependent insulinotropic receptor(Homo sapiens (Human))
Departments Of Discovery Chemistry, Metabolic Diseases, Lead Evaluation, Computer-Assisted Drug Design, Discovery Toxicology, Exploratory Clinical And Translational Research, And Pharmaceutical Candi

Curated by ChEMBL
LigandPNGBDBM50026070(CHEMBL3338183)
Affinity DataEC50: >1.00E+4nMAssay Description:Agonist activity at human GPR119More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlucose-dependent insulinotropic receptor(Homo sapiens (Human))
Departments Of Discovery Chemistry, Metabolic Diseases, Lead Evaluation, Computer-Assisted Drug Design, Discovery Toxicology, Exploratory Clinical And Translational Research, And Pharmaceutical Candi

Curated by ChEMBL
LigandPNGBDBM50026071(CHEMBL3338182)
Affinity DataEC50:  9nMAssay Description:Agonist activity at human GPR119More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlucose-dependent insulinotropic receptor(Homo sapiens (Human))
Departments Of Discovery Chemistry, Metabolic Diseases, Lead Evaluation, Computer-Assisted Drug Design, Discovery Toxicology, Exploratory Clinical And Translational Research, And Pharmaceutical Candi

Curated by ChEMBL
LigandPNGBDBM50026072(CHEMBL3338181)
Affinity DataEC50:  18nMAssay Description:Agonist activity at human GPR119More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlucose-dependent insulinotropic receptor(Homo sapiens (Human))
Departments Of Discovery Chemistry, Metabolic Diseases, Lead Evaluation, Computer-Assisted Drug Design, Discovery Toxicology, Exploratory Clinical And Translational Research, And Pharmaceutical Candi

Curated by ChEMBL
LigandPNGBDBM50026073(CHEMBL3338180)
Affinity DataEC50:  95nMAssay Description:Agonist activity at human GPR119More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlucose-dependent insulinotropic receptor(Homo sapiens (Human))
Departments Of Discovery Chemistry, Metabolic Diseases, Lead Evaluation, Computer-Assisted Drug Design, Discovery Toxicology, Exploratory Clinical And Translational Research, And Pharmaceutical Candi

Curated by ChEMBL
LigandPNGBDBM50026074(CHEMBL3338179)
Affinity DataEC50:  63nMAssay Description:Agonist activity at human GPR119More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlucose-dependent insulinotropic receptor(Homo sapiens (Human))
Departments Of Discovery Chemistry, Metabolic Diseases, Lead Evaluation, Computer-Assisted Drug Design, Discovery Toxicology, Exploratory Clinical And Translational Research, And Pharmaceutical Candi

Curated by ChEMBL
LigandPNGBDBM50026075(CHEMBL3338178)
Affinity DataEC50:  32nMAssay Description:Agonist activity at human GPR119More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlucose-dependent insulinotropic receptor(Homo sapiens (Human))
Departments Of Discovery Chemistry, Metabolic Diseases, Lead Evaluation, Computer-Assisted Drug Design, Discovery Toxicology, Exploratory Clinical And Translational Research, And Pharmaceutical Candi

Curated by ChEMBL
LigandPNGBDBM50026076(CHEMBL3338177)
Affinity DataEC50:  37nMAssay Description:Agonist activity at human GPR119More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlucose-dependent insulinotropic receptor(Homo sapiens (Human))
Departments Of Discovery Chemistry, Metabolic Diseases, Lead Evaluation, Computer-Assisted Drug Design, Discovery Toxicology, Exploratory Clinical And Translational Research, And Pharmaceutical Candi

Curated by ChEMBL
LigandPNGBDBM50026077(CHEMBL3338176)
Affinity DataEC50:  11nMAssay Description:Agonist activity at human GPR119More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlucose-dependent insulinotropic receptor(Homo sapiens (Human))
Departments Of Discovery Chemistry, Metabolic Diseases, Lead Evaluation, Computer-Assisted Drug Design, Discovery Toxicology, Exploratory Clinical And Translational Research, And Pharmaceutical Candi

Curated by ChEMBL
LigandPNGBDBM50026175(CHEMBL3338175)
Affinity DataEC50:  41nMAssay Description:Agonist activity at human GPR119More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlucose-dependent insulinotropic receptor(Homo sapiens (Human))
Departments Of Discovery Chemistry, Metabolic Diseases, Lead Evaluation, Computer-Assisted Drug Design, Discovery Toxicology, Exploratory Clinical And Translational Research, And Pharmaceutical Candi

Curated by ChEMBL
LigandPNGBDBM50026176(CHEMBL3338174)
Affinity DataEC50:  16nMAssay Description:Agonist activity at human GPR119More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlucose-dependent insulinotropic receptor(Homo sapiens (Human))
Departments Of Discovery Chemistry, Metabolic Diseases, Lead Evaluation, Computer-Assisted Drug Design, Discovery Toxicology, Exploratory Clinical And Translational Research, And Pharmaceutical Candi

Curated by ChEMBL
LigandPNGBDBM50026177(CHEMBL3338173)
Affinity DataEC50:  23nMAssay Description:Agonist activity at human GPR119More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlucose-dependent insulinotropic receptor(Homo sapiens (Human))
Departments Of Discovery Chemistry, Metabolic Diseases, Lead Evaluation, Computer-Assisted Drug Design, Discovery Toxicology, Exploratory Clinical And Translational Research, And Pharmaceutical Candi

Curated by ChEMBL
LigandPNGBDBM50026178(CHEMBL3338172)
Affinity DataEC50:  117nMAssay Description:Agonist activity at human GPR119More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Displayed 1 to 50 (of 106 total ) | Next | Last >>
Jump to: